Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin

Cancer Research

Volumn 60, Issue 21, 2000, Pages 6061-6067

  Liu, S ^a   Netzel Arnett, S ^a   Birkedal Hansen, H ^a   Leppla, S H ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; ANTIGEN; CYTOTOXIN; IMMUNOTOXIN; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CELL KILLING; CELL SPECIFICITY; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN TARGETING; TUMOR CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; BINDING SITES; BIOTRANSFORMATION; BREAST NEOPLASMS; CERCOPITHECUS AETHIOPS; COCULTURE TECHNIQUES; COS CELLS; FIBROSARCOMA; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MELANOMA; METALLOENDOPEPTIDASES; MUTATION; TUMOR CELLS, CULTURED; VERO CELLS;

EID: 0034326255     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Immunotoxins in cancer therapy
2. Clinical trials of targeted toxins
3. One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell
4. Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases
5. Purification of the third factor of anthrax toxin
6. The bifactorial Bacillus anthracis lethal and oedema toxins
7. Anthrax Toxins
8. Anthrax protective antigen interacts with a specific receptor on the surface of CHO-K1 cells
9. Anthrax toxin protective antigen is activated by a cell-surface protease with the sequence specificity and catalytic properties of furin
10. Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen
11. Proteolytic activation of anthrax toxin bound to cellular receptors
12. Anthrax protective antigen forms oligomers during intoxication of mammalian cells
13. Identification of residues lining the anthrax protective antigen channel
14. Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin
15. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process
16. Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells
17. Rapid lethal effect in rats of a third component found upon fractionating the toxin of Bacillus anthracis
18. Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin
19. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor
20. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages
21. Anthrax toxin edema factor: A bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells
22. Functional mapping of anthrax toxin lethal factor by in-frame insertion mutagenesis
23. Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells
24. Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides
25. Protective antigen-binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino- or carboxy-terminus
26. Proteolytic remodeling of extracellular matrix
27. Tumor cell interactions with the extracellular matrix during invasion and metastasis
28. The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer
29. Changing views of the role of matrix metalloproteinases in metastasis
30. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors
31. Pro-tumor necrosis factor-α processing activity is tightly controlled by a component that does not affect notch processing
32. Multiple modes of activation of latent human fibroblast collagenase: Evidence for the role of a Cys73 active-site zinc complex in latency and a 'cysteine switch' mechanism for activation
33. Mechanisms for pro matrix metalloproteinase activation
34. Matrix metalloproteinases: A review
35. Matrix metalloproteinase inhibitors: A novel class of anticancer agents
36. Preclinical and clinical studies of MMP inhibitors in cancer
37. Clostridium septicum α-toxin is proteolytically activated by furin
38. Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids
39. A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo
40. Internalization of a Bacillus anthracis protective antigen-c-Myc fusion protein mediated by cell surface anti-c-Myc antibodies
41. Crystal structure of the anthrax toxin protective antigen
42. Sequence specificities of human fibroblast and neutrophil collagenases
43. Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin)
44. The soluble catalytic domain of membrane type I matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3
45. Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants
46. Membrane-type metalloproteinases in tumor invasion
47. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin ανβ3
48. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion
49. Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin